Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance

Michifumi Tokuda, Pipin Kojodjojo, Stanley Tung, Usha B Tedrow, Eyal Nof, Keiichi Inada, Bruce A Koplan, Gregory F Michaud, Roy M John, Laurence M Epstein, William G Stevenson, Michifumi Tokuda, Pipin Kojodjojo, Stanley Tung, Usha B Tedrow, Eyal Nof, Keiichi Inada, Bruce A Koplan, Gregory F Michaud, Roy M John, Laurence M Epstein, William G Stevenson

Abstract

Background: Acute end points of catheter ablation for ventricular tachycardia (VT) remain incompletely defined. The aim of this study is to identify causes for failure in patients with structural heart disease and to assess the relation of this acute outcome to longer-term management and outcomes.

Methods and results: From 2002 to 2010, 518 consecutive patients (84% male, 62 ± 14 years) with structural heart disease underwent a first ablation procedure for sustained VT at our institution. Acute ablation failure was defined as persistent inducibility of a clinical VT. Acute ablation failure was seen in 52 (10%) patients. Causes for failure were: intramural free wall VT in 13 (25%), deep septal VT in 9 (17%), decision not to ablate due to proximity to the bundle of His, left phrenic nerve, or a coronary artery in 3 (6%), and endocardial ablation failure with inability or decision not to attempt to access the epicardium in 27 (52%) patients. In multivariable analysis, ablation failure was an independent predictor of mortality (hazard ratio 2.010, 95% CI 1.147 to 3.239, P=0.004) and VT recurrence (hazard ratio 2.385, 95% CI 1.642 to 3.466, P<0.001).

Conclusions: With endocardial or epicardial ablation, or both, acute ablation failure was seen in 10% of patients, largely due to anatomic factors. Persistence of a clinical VT is associated with recurrence and comparatively higher mortality.

Keywords: catheter ablation; failure; outcome; structural heart disease; ventricular tachycardia.

Figures

Figure 1.
Figure 1.
Flow chart and causes of ablation failure. After endocardial mapping, 101 (23%) had failed ablation. Epicardial mapping was performed in 64 patients, which resulted in acute procedural success in an additional 49 patients. Thus, 52 (12%) were acute failures. ENDO indicates endocardial; EPI, epicardial; VT, ventricular tachycardia.
Figure 2.
Figure 2.
Example of septal origin. (A) Merged RV and LV activation maps of VT indicating the earliest activation during VT is located at the mid septum. (B) Sustained monomorphic VT with a cycle length of 540 ms is present. The first 2 beats of a train of stimuli at a cycle length of 490 ms is shown. The VT is continually reset without an alteration in the QRS morphology consistent with entrainment with concealed fusion. The stimulus‐to‐QRS interval is 60 ms. As shown in the last beat of the tracing, the electrocardiogram onset at the recording site occurs 60 ms before the QRS onset. Thus, the stimulus‐to‐QRS interval matches the electrocardiogram‐to‐QRS interval. The postpacing interval matches the VT cycle length of 540 ms. These findings are consistent with pacing at a reentry circuit site near an “exit”. ABLd indicates bipolar intracardiac recordings from the distal electrode pair of the mapping catheter at left ventricular site; ABLp, those from the proximal pair; RV, right ventricle; LV, left ventricle; VT, ventricular tachycardia; Uni, unipolar recordings; d, distal; m, middle; p, proximal.
Figure 3.
Figure 3.
Overall attributed causes of ablation failure are shown.
Figure 4.
Figure 4.
Kaplan–Meier curves showing all cause mortality in the patients with ablation success, those with ablation failure, and those who did not have a postablation attempt to reinduce VT. All 518 patients were included in this survival analysis. In pairwise comparison, Bonferroni adjusted P<0.05/3 was considered significant. VT indicates ventricular tachycardia.
Figure 5.
Figure 5.
Kaplan–Meier curves showing VT recurrence within 1 year after catheter ablation in the patients with ablation success, those with ablation failure and those who did not have a post ablation attempt to re‐induce VT. All 518 patients were included in this survival analysis. In pairwise comparison, Bonferroni adjusted P<0.05/3 was considered significant. VT indicates ventricular tachycardia.
Figure 6.
Figure 6.
Kaplan–Meier curves showing all cause mortality in the patients with mappable VT only and those with at least 1 unmappable VT. All 518 patients were included in this survival analysis. P value is from the log‐rank test. VT indicates ventricular tachycardia.
Figure 7.
Figure 7.
Kaplan–Meier curves showing VT recurrence within 1 year after catheter ablation in the patients with mappable VT only and those with at least 1 unmappable VT. All 518 patients were included in this survival analysis. P value is from the log‐rank test. VT indicates ventricular tachycardia.

References

    1. Mark DB, Anstrom KJ, Sun JL, Clapp‐Channing NE, Tsiatis AA, Davidson‐Ray L, Lee KL, Bardy GHSudden Cardiac Death in Heart Failure Trial Investigators Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med. 2008; 359:999-1008
    1. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008; 359:1009-1017
    1. Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T, Gonzalez MD, Worley SJ, Daoud EG, Hwang C, Schuger C, Bump TE, Jazayeri M, Tomassoni GF, Kopelman HA, Soejima K, Nakagawa HMulticenter Thermocool VT Ablation Trial Investigators Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the Multicenter Thermocool Ventricular Tachycardia Ablation Trial. Circulation. 2008; 118:2773-2782
    1. Aliot EM, Stevenson WG, Almendral‐Garrote JM, Bogun F, Calkins CH, Delacretaz E, Della Bella P, Hindricks G, Jaïs P, Josephson ME, Kautzner J, Kay GN, Kuck KH, Lerman BB, Marchlinski F, Reddy V, Schalij MJ, Schilling R, Soejima K, Wilber D. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2009; 6:886-933
    1. Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter‐defibrillators: short‐ and long‐term outcomes in a prospective single‐center study. Circulation. 2008; 117:462-469
    1. Tanner H, Hindricks G, Volkmer M, Furniss S, Kühlkamp V, Lacroix D, DE Chillou C, Almendral J, Caponi D, Kuck KH, Kottkamp H. Catheter ablation of recurrent scar‐related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro‐VT‐study. J Cardiovasc Electrophysiol. 2010; 21:47-53
    1. Sauer WH, Zado E, Gerstenfeld EP, Marchlinski FE, Callans DJ. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter‐defibrillator. Heart Rhythm. 2010; 7:9-14
    1. Tokuda M, Tedrow UB, Kojodjojo P, Inada K, Koplan BA, Michaud GF, John RM, Epstein LM, Stevenson WG. Catheter ablation of ventricular tachycardia in nonischemic heart disease. Circ Arrhythm Electrophysiol. 2012; 5:992-1000
    1. Raymond JM, Sacher F, Winslow R, Tedrow U, Stevenson WG. Catheter ablation for scar‐related ventricular tachycardias. Curr Probl Cardiol. 2009; 34:225-270
    1. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000; 101:1288-1296
    1. Soejima K, Suzuki M, Maisel WH, Brunckhorst CB, Delacretaz E, Blier L, Tung S, Khan H, Stevenson WG. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation. 2001; 104:664-669
    1. Soejima K, Stevenson WG, Maisel WH, Sapp JL, Epstein LM. Electrically unexcitable scar mapping based on pacing threshold for identification of the reentry circuit isthmus: feasibility for guiding ventricular tachycardia ablation. Circulation. 2002; 106:1678-1683
    1. Sosa E, Scanavacca M, d'Avilla A, Pillegi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996; 7:531-536
    1. Soejima K, Couper G, Cooper JM, Sapp JL, Epstein LM, Stevenson WG. Subxiphoid surgical approach for epicardial catheter‐based mapping and ablation in patients with prior cardiac surgery or difficult pericardial access. Circulation. 2004; 110:1197-1201
    1. Stevenson WG, Couper GS. A surgical option for ventricular tachycardia caused by nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2011; 4:429-431
    1. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh JCKD‐EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150:604-612
    1. Roberts‐Thomson KC, Steven D, Seiler J, Inada K, Koplan BA, Tedrow UB, Epstein LM, Stevenson WG. Coronary artery injury due to catheter ablation in adults: presentations and outcomes. Circulation. 2009; 120:1465-1473
    1. Sanchez‐Quintana D, Cabrera JA, Climent V, Farr′e J, Weiglein A, Ho SY. How close are the phrenic nerves to cardiac structures? Implications for cardiac interventionalists. J Cardiovasc Electrophysiol. 2005; 16:309-313
    1. Buch E, Vaseghi M, Cesario DA, Shivkumar K. A novel method for preventing phrenic nerve injury during catheter ablation. Heart Rhythm. 2007; 4:95-98
    1. Matsuo S, Jais P, Knecht S, Lim KT, Hocini M, Derval N, Wright M, Sacher F, Ha¨õssaguerre M. Images in cardiovascular medicine. Novel technique to prevent left phrenic nerve injury during epicardial catheter ablation. Circulation. 2008; 117:e471.
    1. Roberts‐Thomson KC, Seiler J, Steven D, Inada K, Michaud GF, John RM, Koplan BA, Epstein LM, Stevenson WG, Tedrow UB. Percutaneous access of the epicardial space for mapping ventricular and supraventricular arrhythmias in patients with and without prior cardiac surgery. J Cardiovasc Electrophysiol. 2010; 21:406-411
    1. Sacher F, Sobieszczyk P, Tedrow U, Eisenhauer AC, Field ME, Selwyn A, Raymond JM, Koplan B, Epstein LM, Stevenson WG. Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm. 2008; 5:62-68
    1. Tokuda M, Sobieszczyk P, Eisenhauer AC, Kojodjojo P, Inada K, Koplan BA, Michaud GF, John RM, Epstein LM, Sacher F, Stevenson WG, Tedrow UB. Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol. 2011; 4:889-896
    1. Thiagalingam A, Campbell CR, Boyd A, Ross DL, Kovoor P. Catheter intramural needle radiofrequency ablation creates deeper lesions than irrigated tip catheter ablation. Pacing Clin Electrophysiol. 2003; 26:2146-2150
    1. Sapp JL, Cooper JM, Zei P, Stevenson WG. Large radiofrequency ablation lesions can be created with a retractable infusion‐needle catheter. J Cardiovasc Electrophysiol. 2006; 17:657-661
    1. Della Bella P, Riva S, Fassini G, Giraldi F, Berti M, Klersy C, Trevisi N. Incidence and significance of pleomorphism in patients with postmyocardial infarction ventricular tachycardia. Acute and long‐term outcome of radiofrequency catheter ablation. Eur Heart J. 2004; 25:1127-1138
    1. Rothman SA, Hsia HH, Cossú SF, Chmielewski IL, Buxton AE, Miller JM. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long‐term success and the significance of inducible nonclinical arrhythmias. Circulation. 1997; 96:3499-3508
    1. Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM, Trusso J, Carlson M, Luceri R, Kopelman H, Wilber D, Wharton JM, Stevenson WG. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi‐Center Investigators Group. J Am Coll Cardiol. 2000; 35:1905-1914

Source: PubMed

3
Subscribe